Following the exciting 2022 in-person Communiqué Awards, we are pleased to offer our readers a selection of case studies that ...

PMEA returned on 21 November at the Sheraton Grand in London to recognise excellence within pharmaceutical marketing. The ...

Pfizer’s Hympavzi (marstacimab) has been approved by the European Commission (EC) to treat haemophilia A or B in adult and ...

Communicating complex medical information has the potential to overwhelm patients and caregivers. The key is blending ...

Patient recruitment and retention company, Innovative Trials, was shortlisted as a finalist in the PME Award for its ...

In 2022, there is a renewed focus on diversity, equity and inclusion (DE&I) in the workplace. But for DE&I to be successful, ...

Innovative Trials is a prominent international company specializing in patient recruitment and retention for clinical trials. Boasting 14 years of experience, Innovative Trials provides three ...

Professor Brian D Smith is an authority on the pharmaceutical industry and works at SDA Bocconi University and Hertfordshire Business School.

What makes a story powerful? Storytelling is becoming more critical than ever. In medical publications, healthcare providers ...

We start by asking ‘what is the business challenge that communications can solve?’ Then, for every client, brand and brief, we combine strategy, science and a dose of creativity with a deeply human ...

UCB’s Bimzelx (bimekizumab-bkzx) has been approved by the US Food and Drug Administration (FDA) to treat active moderate-to-severe hidradenitis suppurativa (HS) in adults. Estimated to affect one in ...